Safety of Influenza A (H1N1) 2009 Monovalent Vaccines -- United States, October 1-November 24, 2009

Broder, K.; Vellozzi, C.; Weinbaum, C.; Zheteyeva, Y.; Tosh, P.; Rao, A.; Hocevar, S.; Esposito, D.
December 2009
MMWR: Morbidity & Mortality Weekly Report;12/11/2009, Vol. 58 Issue 48, p1351
The article focuses on a study which assessed the safety of H1N1 vaccines in the U.S. The Centers for Disease Control and Prevention (CDC) reviewed the vaccine safety reports for H1N1 vaccines that were received through the U.S. Vaccine Adverse Event Reporting System (VAERS). The reports submitted to VAERS revealed the adverse events associated with H1N1 vaccine, such as anaphylaxis, allergy and Guillain-Barré syndrome. They also showed 13 cases of mortality following the administration of H1N1 vaccine.


Related Articles

  • Influenza A virus vaccine-H1N1.  // Reactions Weekly;11/3/2012, Issue 1426, p27 

    The article describes the case of a man born in 1989 who developed narcolepsy and multiple sclerosis after vaccination with influenza A virus vaccine-H1N1.

  • Update on H1N1 vaccine ADRs from Malaysia.  // Reactions Weekly;12/18/2010, Issue 1332, p3 

    The article deals with the adverse drug reactions (ADR) experienced by 861 individuals following administration of H1N1 vaccines in Malaysia as of June 2010.

  • Australian experience with non-adjuvant H1N1 vaccine (Panvax and Panvax Junior). Cook, Jane // Australian Prescriber;Aug2010, Vol. 33 Issue 4, p121 

    The H1N1 influenza vaccination program used strategies to encourage consumers and health professionals to report adverse events to allow the TGA to closely monitor safety of the vaccine. Information is now available about the number and types of adverse reactions reported during the first six...

  • Benefit-risk balance for H1N1 pandemic meds remains positive.  // Reactions Weekly;1/16/2010, Issue 1284, p2 

    This article reports on the benefit-risk balance for the use of H1N1 vaccines. The fifth weekly H1N1 pandemic pharmacovigilance update issued by the European Medicines Agency (EMA) discussed the potential adverse effects of the vaccines. The report linked the use of the vaccines to...

  • ANALIZA SUSPEKTNIH NEŽELJENIH REAKCIJA POSLE IMUNIZACIJE PROTIV PANDEMIJSKOG GRIPA A (H1N1) 2009. PETROVIĆ, Vladimir; ŠEGULJEV, Zorica; MEDIĆ, Snežana; RISTIĆ, Mioljub; TOMIĆ, Slađana; CVETIĆ, Gordana // Medicinski Pregled / Medical Review;2011, Vol. 64 Issue 5/6, p305 

    No abstract available.

  • Monitoring Adverse Events of the Vaccination Campaign Against Influenza A (H1N1) in the Netherlands. van Puijenbroek, Eugène P.; Broos, Nancy; van Grootheest, Kees // Drug Safety;2010, Vol. 33 Issue 12, p1097 

    Background: In November 2009, a vaccination campaign against Influenza A (H1N1) was started in the Netherlands. The accelerated registration procedure of the vaccines used in this campaign and the use of these vaccines on a large scale indicated a need for real-time safety monitoring. Objective:...

  • Fever Following Immunization with Influenza A (H1N1) Vaccine in Children: A Survey-Based Study in the Netherlands. Broos, Nancy; van Puijenbroek, Eugène P.; van Grootheest, Kees // Drug Safety;2010, Vol. 33 Issue 12, p1109 

    Background: In November 2009, all children in the Netherlands from 6 months up to 4 years of age were indicated to receive the Influenza A (H1N1) vaccine. Fever is a common adverse event following immunization in children. Pandemrix®, an inactivated, split-virus influenza A (Hi N 1) vaccine,...

  • The Safety of H1N1 Vaccine in Children in Saudi Arabia: A Cohort Study Using Modem Technology in a Developing Country. Aljadhey, Hisham; Alyabsi, Mesnad; Alrwisan, Adel; Alqahtani, Nasser; Almutairi, Reem; Al Tawil, Esraa; Adam, Mansour; Shakir, Saad; Aljeraisy, Majed; Al-Blowi, Ali; Alkhashan, Hesham; Albogami, Yasser; Murray, Michael D. // Drug Safety;2012, Vol. 35 Issue 7, p555 

    Background: With its rapid introduction in 2009, concerns about the safety of the H1N1 vaccines have been raised. Data were especially limited on the pediatric safety of H1N1 vaccine in Saudi Arabia. Objectives: The objectives of this study were to investigate the safety of the H1N1 vaccine...

  • Ophthalmic consequences of the H1N1 flu vaccine raise concern among surgeons. Cimberle, Michela // Ocular Surgery News Asia-Pacific;May2010, Vol. 21 Issue 3, p21 

    The article discusses possible immune-related ophthalmic consequences of the H1N1 flu vaccine. In one case, a patient reportedly had bilateral graft rejection one day following vaccination, and was aggressively treated with topical steroids to regain the corrected vision, although many...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics